Literature DB >> 3521500

Further discussion concerning porphyria cutanea tarda and TCDD exposure.

R E Jones, M Chelsky.   

Abstract

Past reports have correlated a diagnosis of porphyria cutanea tarda (PCT) with exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Re-examination of the literature, however, has caused us to question the conclusion of a relationship between acquired PCT and TCDD. The major considerations at issue were: (1) whether the diagnostic label of PCT was applied excessively to cases with findings that are nonspecific; (2) whether the clinical conditions suggestive of PCT were the likely results of exposure to another chemical, for example hexachlorobenzene (HCB); and (3) whether a causal link between PCT and TCDD is reasonably substantiated by the facts. Based on the re-evaluation of the literature, the known effects of HCB and TCDD, and the follow-up results from the chemical plant, we submit that HCB alone, or HCB in combination with other polychlorinated aromatic hydrocarbons, may have been responsible for the effects observed and the subsequent correlation to PCT.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521500     DOI: 10.1080/00039896.1986.9937417

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  3 in total

Review 1.  [Hepatic porphyrias and alcohol].

Authors:  M O Doss; A Kühnel; U Gross; I Sieg
Journal:  Med Klin (Munich)       Date:  1999-06-15

2.  Serum organochlorines and urinary porphyrin pattern in a population highly exposed to hexachlorobenzene.

Authors:  Jordi Sunyer; Carmen Herrero; Dolores Ozalla; Maria Sala; Núria Ribas-Fitó; Joan Grimalt; Xavier Basagaña
Journal:  Environ Health       Date:  2002-07-19       Impact factor: 5.984

3.  A morbidity study of former pentachlorophenol-production workers.

Authors:  D O Hryhorczuk; W H Wallace; V Persky; S Furner; J R Webster; D Oleske; B Haselhorst; R Ellefson; C Zugerman
Journal:  Environ Health Perspect       Date:  1998-07       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.